IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
IVTCC
An International VT Ablation Center Collaborative Group (IVTCC): A Multicenter Ventricular Tachycardia Catheter Ablation Registry
1 other identifier
observational
10,000
7 countries
41
Brief Summary
This is a prospective multi-center international registry. The objective of this registry is to collect prospective data on patients undergoing catheter ablation for Ventricular Tachycardia (VT) and Premature Ventricular Contractions (PVC). The registry will be used for clinical monitoring, research, and quality improvement purposes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2018
Longer than P75 for all trials
41 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2018
CompletedFirst Submitted
Initial submission to the registry
July 10, 2020
CompletedFirst Posted
Study publicly available on registry
August 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2027
December 15, 2025
December 1, 2025
8 years
July 10, 2020
December 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ventricular tachycardia (VT) recurrence
Freedom from ventricular tachycardia episodes requiring ICD Intervention (shock or Anti-Tachycardia Pacing) or repeat procedure.
From date of procedure assessed by shock, Anti-Tachycardia Pacing, or repeat procedure, up to 10 years.
Secondary Outcomes (2)
Rate of complications
From date of procedure assessed up to 12 months.
Time to transplant or death
From date of procedure assessed by date of transplant and/or death, up to 10 years.
Eligibility Criteria
Patients with ventricular arrhythmias that undergo catheter ablation for ventricular tachycardia or premature ventricular contractions.
You may qualify if:
- \- All patients undergoing catheter ablation for ventricular tachycardia (VT) or premature ventricular contractions (PVCs).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (41)
Banner Health, University of Arizona Medical Center
Phoenix, Arizona, 85719, United States
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
University of California, Los Angeles
Los Angeles, California, 90095, United States
University of California, Davis
Sacramento, California, 95817, United States
University of California San Francisco
San Francisco, California, 94143, United States
University of Colorado Hospital
Aurora, Colorado, 80045, United States
Hartford HealthCare
Hartford, Connecticut, 06103, United States
University of Florida Health
Gainesville, Florida, 32610, United States
The Kansas City Heart Rhythm Institute
Kansas City, Kansas, 66211, United States
University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
Johns Hopkins Heart and Vascular Institute
Baltimore, Maryland, 21287, United States
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
UMass Memorial Health Care
Worcester, Massachusetts, 01655, United States
University of Michigan Frankel Cardiovascular Center
Ann Arbor, Michigan, 48109, United States
University of Minnesota VA Medical Center
Minneapolis, Minnesota, 55417, United States
Mayo Clinic
Rochester, Minnesota, 55902, United States
Washington University in St. Louis
St Louis, Missouri, 63130, United States
The Mount Sinai Hospital
New York, New York, 10029, United States
Columbia University Irving Medical Center
New York, New York, 10032, United States
Montefiore Medical Center
The Bronx, New York, 10461, United States
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
Oregon Health & Science University
Portland, Oregon, 97239, United States
Children's Hospital of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
University of Pennsylvania Health System
Philadelphia, Pennsylvania, 19104, United States
Wellspan Health
York, Pennsylvania, 17403, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Vanderbilt Heart and Vascular Institute
Nashville, Tennessee, 37232, United States
Texas Cardiac Arrhythmia Institute at St. David's Medical Center
Austin, Texas, 78705, United States
Houston Methodist Hospital
Houston, Texas, 77030, United States
University of Utah Health
Salt Lake City, Utah, 84132, United States
University of Virginia Health System
Charlottesville, Virginia, 22903, United States
University of Washington Medical Center
Seattle, Washington, 98195, United States
The Montreal Heart Institute
Montreal, Canada
Shaare Zedek Medical Center
Jerusalem, Israel
Dokkyo Medical University Koshigaya Hospital
Koshigaya, Japan
Leiden University
Leiden, Netherlands
Erasmus Medical Center
Rotterdam, Netherlands
Gregorio Marañón General University Hospital
Madrid, Spain
St. George's Hospital
Wandsworth, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason Bradfield, MD
University of California, Los Angeles
- STUDY CHAIR
Kalyanam Shivkumar, MD, PhD
University of California, Los Angeles
- STUDY CHAIR
Paolo Della Bella, MD
San Raffaele Hospital, Italy
- STUDY CHAIR
Francis Marchlinski, MD, FACC, FAHA, FHRS
University of Pennsylvania Health System
- STUDY CHAIR
Andrea Natale, MD, FACC, FHRS, FESC
Texas Cardiac Arrhythmia Institute at St. David's Medical Center
- STUDY CHAIR
William G Stevenson, MD
Vanderbilt Heart and Vascular Institute
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Specialized Program for Ventricular Tachycardia
Study Record Dates
First Submitted
July 10, 2020
First Posted
August 20, 2020
Study Start
December 1, 2018
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
November 1, 2027
Last Updated
December 15, 2025
Record last verified: 2025-12